Your browser doesn't support javascript.
loading
Real-World Treatment Patterns and Outcomes of First-Line Immunotherapy Among Patients With Advanced Nonsquamous NSCLC Harboring BRAF, MET, or HER2 Alterations.
Garassino, Marina C; Oskar, Sabine; Arunachalam, Ashwini; Zu, Ke; Kao, Yu-Han; Chen, Cai; Meng, Weilin; Pietanza, M Catherine; Zhao, Bin; Aggarwal, Himani.
Afiliação
  • Garassino MC; Thoracic Oncology Program, Section of Hematology Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Oskar S; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, New Jersey.
  • Arunachalam A; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, New Jersey.
  • Zu K; Epidemiology, Merck & Co., Inc., Rahway, New Jersey.
  • Kao YH; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, New Jersey.
  • Chen C; Data, AI and Genome Sciences (DAGS) Department, Merck & Co., Inc., Rahway, New Jersey.
  • Meng W; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, New Jersey.
  • Pietanza MC; Clinical Research, Merck & Co., Inc., Rahway, New Jersey.
  • Zhao B; Clinical Research, Merck & Co., Inc., Rahway, New Jersey.
  • Aggarwal H; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, New Jersey.
JTO Clin Res Rep ; 4(10): 100568, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37744307

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article